31st week of 2021 patent applcation highlights part 9 |
Patent application number | Title | Published |
20210236410 | HAIR COSMETIC COMPRISING BLOCK COPOLYMER | 2021-08-05 |
20210236411 | BLOCK COPOLYMER-CONTAINING INORGANIC PARTICLE DISPERSION FOR COSMETICS | 2021-08-05 |
20210236412 | COSMETIC COMPOSITION OF NON-AQUEOUS THIXOTROPIC NAIL VARNISH CONTAINING A NAIL-HARDENING AGENT, USE AND IMPLEMENTATION METHOD | 2021-08-05 |
20210236413 | RAPID ESTABLISHMENT AND/OR TERMINATION OF SUBSTANTIAL STEADY-STATE DRUG DELIVERY | 2021-08-05 |
20210236414 | METHOD AND SYSTEM FOR DRUG DELIVERY | 2021-08-05 |
20210236415 | SYNTHESIS AND APPLICATION OF MICROBUBBLE-FORMING COMPOUNDS | 2021-08-05 |
20210236416 | TREATMENT OF SKIN DISORDERS WITH TOPICAL ROFLUMILAST COMBINATION COMPOSITIONS | 2021-08-05 |
20210236417 | TRANSDERMAL DELIVERY OF DRONABINOL | 2021-08-05 |
20210236418 | Composition and Method for Oral Treatment of Leukemia | 2021-08-05 |
20210236419 | STEROIDAL COMPOSITIONS AND METHOD OF MAKING AND USE | 2021-08-05 |
20210236420 | Manufacturing of Semi-Plastic Pharmaceutical Dosage Units | 2021-08-05 |
20210236421 | GASTRORETENTIVE DOSAGE FORMS FOR SUSTAINED DRUG DELIVERY | 2021-08-05 |
20210236422 | NASAL SPRAY FORMULATION HAVING EPISTAXIS PREVENTION PROPERTIES | 2021-08-05 |
20210236423 | TOPICAL MONTELUKAST FORMULATIONS | 2021-08-05 |
20210236424 | BINARY LIPID BILAYER-CONTAINING VESICLES COMPRISING EMBEDDED CYTOTOXIC AGENTS AND METHODS OF MAKING AND USING THE SAME | 2021-08-05 |
20210236425 | NEW TREATMENT OF INTERSTITIAL LUNG DISEASES | 2021-08-05 |
20210236426 | IMPROVED PHARMACEUTICAL FORMULATIONS | 2021-08-05 |
20210236427 | Development of Lipid Matrix Granules with Incorporation of Polysaccharides for Effective Delivery of an Antimicrobial Essential Oil | 2021-08-05 |
20210236428 | SYSTEM AND METHOD FOR ISOLATING EXTRACELLULAR VESICLES | 2021-08-05 |
20210236429 | EXTENDED RELEASE COMPOSITIONS COMPRISING PYRIDOSTIGMINE | 2021-08-05 |
20210236430 | SINGLE LAYER CHEWABLE TABLET COMPRISING CETIRIZINE | 2021-08-05 |
20210236431 | PROCESS FOR THE PRODUCTION OF COMPRESSED TABLETS | 2021-08-05 |
20210236432 | COMPOSITIONS COMPRISING ROFLUMILAST FOR TREATING HIDRADENITIS SUPPURATIVA AND PRURIGO NODULARIS | 2021-08-05 |
20210236433 | METHODS AND SYSTEMS FOR FORMING LAYERED SOLID PARTICLES | 2021-08-05 |
20210236434 | COMPOSITIONS COMPRISING UROLITHIN A AND USES THEREOF IN TREATING KIDNEY INJURY | 2021-08-05 |
20210236435 | Nanoparticles | 2021-08-05 |
20210236436 | STABILIZED MENTHOL AND OTHER VOLATILE COMPOUND COMPOSITIONS AND METHODS | 2021-08-05 |
20210236437 | SOFT GEL CAPSULE COMPRISING A SELECTIVE ESTROGEN RECEPTOR MODULATOR | 2021-08-05 |
20210236438 | COMPOUNDS AND METHODS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER AND OTHER NEUROLOGICAL OR PSYCHIATRIC DISORDERS | 2021-08-05 |
20210236439 | NEW SALT OF CYSTEAMINE FOR THE PREPARATION OF HIGHLY RESPIRABLE PARTICLES | 2021-08-05 |
20210236440 | FIXED DOSE COMPOSITION OF PARACETAMOL: AMITRIPTYLINE AND METHOD FOR THE TREATMENT OF MIXED CANCER PAIN | 2021-08-05 |
20210236441 | TREATMENT OF SPONDYLOARTHRITIS | 2021-08-05 |
20210236442 | METHODS FOR DELAYING OCCURRENCE OF NEW-ONSET TYPE 2 DIABETES AND FOR SLOWING PROGRESSION OF AND TREATING TYPE 2 DIABETES | 2021-08-05 |
20210236443 | METHOD OF TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS, NASH | 2021-08-05 |
20210236444 | MEDICINAL PRODUCT, ANTICANCER AGENT, MEDICINAL INTERMEDIATE PRODUCT, AND METHOD FOR PRODUCING CYCLIC CARBOXYLIC ACID COMPOUND OR DERIVATIVE THEREOF | 2021-08-05 |
20210236445 | BACLOFEN AND ACAMPROSATE BASED THERAPY OF ALZHEIMER'S DISEASE IN PATIENTS HAVING LOST RESPONSIVENESS TO ACETYLCHOLINESTERASE INHIBITOR THERAPY | 2021-08-05 |
20210236446 | WOUND HEALING COMPOSITION | 2021-08-05 |
20210236447 | DHA ENRICHED POLYUNSATURATED FATTY ACID COMPOSITIONS | 2021-08-05 |
20210236448 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | 2021-08-05 |
20210236449 | USE OF CHLOROGENIC ACID IN PREPARING DRUG FOR PREVENTING OR BLOCKING BRAIN AND/OR BONE METASTASES OF LUNG CANCER | 2021-08-05 |
20210236450 | Methods and Compositions for Preventing and Treating Auditory Dysfunctions | 2021-08-05 |
20210236451 | Medicine with dicaffeoylquinic acid from Artemisia selengensis for treating gout | 2021-08-05 |
20210236452 | EXOGENOUS KETONE SUPPLEMENTS FOR REDUCING ANXIETY-RELATED BEHAVIOR | 2021-08-05 |
20210236453 | METHOD FOR TREATING RHEUMATOID ARTHRITIS | 2021-08-05 |
20210236454 | METHOD OF TREATING CANCER | 2021-08-05 |
20210236455 | PURIFIED FORMS OF ROFECOXIB, METHODS OF MANUFACTURE AND USE | 2021-08-05 |
20210236456 | COMPOSITIONS AND DOSAGE FORMS FOR ORAL DELIVERY | 2021-08-05 |
20210236457 | FORMULATION FOR PAIN MANAGEMENT | 2021-08-05 |
20210236458 | FORMULATION FOR PAIN MANAGEMENT | 2021-08-05 |
20210236459 | COMPOSITION FOR BUCCAL OR SUBLINGUAL ADMINISTRATION OF CANNABIS EXTRACT AND METHODS FOR MAKING SAME | 2021-08-05 |
20210236460 | Applications of Known and Novel Cannabinoids | 2021-08-05 |
20210236461 | AGENT FOR ELIMINATING SENESCENT CELLS | 2021-08-05 |
20210236462 | SUSTAINED RELEASE LINGUAL THIOCTIC ACID DELIVERY SYSTEMS | 2021-08-05 |
20210236463 | beta-LACTAMASE INHIBITOR | 2021-08-05 |
20210236464 | BENZOSELENOPHENE-BASED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND ANTIBODY-DRUG CONJUGATES INCLUDING THE SAME | 2021-08-05 |
20210236465 | METHODS AND COMPOSITIONS FOR TREATING HETEROTOPIC OSSIFICATION | 2021-08-05 |
20210236466 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | 2021-08-05 |
20210236467 | DANTROLENE FORMULATIONS AND METHODS OF THEIR USE | 2021-08-05 |
20210236468 | COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING A VASCULAR DISRUPTING AGENT AND TAXANE COMPOUND | 2021-08-05 |
20210236469 | FATTY ACIDS AS ANTI-INFLAMMATORY AGENTS | 2021-08-05 |
20210236470 | PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE | 2021-08-05 |
20210236471 | RILUZOLE PRODRUGS AND THEIR USE | 2021-08-05 |
20210236472 | COMBINATION THERAPY FOR TREATMENT OF RESTENOSIS | 2021-08-05 |
20210236473 | TETRAHYDRO- PYRIDO[3,4- b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | 2021-08-05 |
20210236474 | IMIDAZO[4,5-C]PYRIDINE COMPOUNDS AS LSD-1 INHIBITORS | 2021-08-05 |
20210236475 | ANTITUMOR AGENT AND METHOD FOR TUMOR THERAPY | 2021-08-05 |
20210236476 | METHODS OF TREATING CANCER WITH SMALL MOLECULE PD-L1 INHIBITORS | 2021-08-05 |
20210236477 | COMBINATION THERAPY | 2021-08-05 |
20210236478 | Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists | 2021-08-05 |
20210236479 | PHARMACEUTICAL COMPOUNDS FOR USE IN TREATING HUNTINGTON'S DISEASE | 2021-08-05 |
20210236480 | PARTICLE AND PHARMACEUTICAL COMPOSITION COMPRISING AN INSOLUBLE CAMPTOTHECIN COMPOUND WITH DOUBLE CORE-SHELL STRUCTURE AND METHOD FOR MANUFACTURING THE SAME | 2021-08-05 |
20210236481 | COMPOSITION AND METHODS OF USE OF NOVEL PHENYLALANINE SMALL ORGANIC COMPOUNDS TO DIRECTLY MODULATE PCSK9 PROTEIN ACTIVITY | 2021-08-05 |
20210236482 | RADIATION SENSITIVITY ENHANCING COMPOSITION CONTAINING ARIPIPRAZOLE AS ACTIVE INGREDIENT | 2021-08-05 |
20210236483 | SOLUTION FOR ORAL ADMINISTRATION | 2021-08-05 |
20210236484 | METHOD OF REDUCING PULMONARY EXACERBATIONS IN RESPIRATORY DISEASE PATIENTS | 2021-08-05 |
20210236485 | REPEATED ADMINISTRATION OF DIHYDROERGOTAMINE FOR TREATMENT OF FREQUENT MIGRAINE HEADACHES | 2021-08-05 |
20210236486 | TREATING UNTREATED OR TREATMENT-RESISTANT DIABETES WITH GLUCOKINASE ACTIVATOR | 2021-08-05 |
20210236487 | Methods and Compositions for Treatment of Cancer with PARP Inhibitors | 2021-08-05 |
20210236488 | IMATINIB FOR USE IN THE TREATMENT OF STROKE | 2021-08-05 |
20210236489 | AMORPHOUS SOLID DISPERSIONS OF DASATINIB AND USES THEREOF | 2021-08-05 |
20210236490 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF HAIR LOSS | 2021-08-05 |
20210236491 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF HAIR LOSS | 2021-08-05 |
20210236492 | METHOD FOR TREATING PANCREATIC CANCER | 2021-08-05 |
20210236493 | FUSED TRICYCLIC COMPOUNDS AND USES THEREOF IN MEDICINE | 2021-08-05 |
20210236494 | THERAPEUTIC COMBINATION | 2021-08-05 |
20210236495 | Compounds and Their Use for Reducing Uric Acid Levels | 2021-08-05 |
20210236496 | TREATMENT OF RSV WITH COMBINATION PRODUCT | 2021-08-05 |
20210236497 | METHOD FOR TREATING CORONAVIRUS INFECTIONS | 2021-08-05 |
20210236498 | Methods of Treating Steroid Resistant Diseases and Conditions | 2021-08-05 |
20210236499 | IMIPRIDONES FOR GLIOMAS | 2021-08-05 |
20210236500 | INHIBITION OF AUTOPHAGY USING PHOSPHOLIPASE A2 INHIBITORS | 2021-08-05 |
20210236501 | COMBINATION THERAPY FOR PI3K-ASSOCIATED DISEASE OR DISORDER | 2021-08-05 |
20210236502 | THERAPEUTIC OR PREVENTING AGENT FOR NEPHROTIC SYNDROME INCLUDING INDOLE COMPOUND | 2021-08-05 |
20210236503 | THERAPEUTIC OR PREVENTING AGENT FOR MULTIPLE SCLEROSIS INCLUDING INDOLE COMPOUND | 2021-08-05 |
20210236504 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CANCER PATIENT STRATIFICATION AND CANCER TREATMENT | 2021-08-05 |
20210236505 | SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS | 2021-08-05 |
20210236506 | NOVEL USES | 2021-08-05 |
20210236507 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING RELAPSE IN A PERSON WITH AN ADDICTION USING BETA ADRENERGIC RECEPTOR ANTAGONIST AND MUSCARINIC RECEPTOR ANTAGONIST COMBINATIONS | 2021-08-05 |
20210236508 | BROMODOMAIN INHIBITORS | 2021-08-05 |
20210236509 | OPTIMISED DOSAGE OF DIAMINOPHENOTHIAZINES IN POPULATIONS | 2021-08-05 |